We have located links that may give you full text access.
Predictors of aortic stenosis severity reclassification with imaging data fusion method in patients qualified for TAVI.
Kardiologia Polska 2018 September 14
B: ACKGROUND: Imaging data fusion method (IDFM) with multislice computed tomography (MSCT) and two-dimensional transthoracic echocardiography (2D-TTE) in aortic stenosis (AS) may result in reclassification from severe to non-severe AS.
AIM: The aim of the study was to establish potential predictors of AS reclassification with IDFM method.
METHODS: 54 high-risk patients (mean age 79±7.9 years; 40.7% male) with severe AS by 2D-TTE (indexed aortic valve area [AVAi] < 0.6 cm²/m²), qualified for transcatheter aortic valve implantation (TAVI), were included in the analysis. AVAi was then recalculated with IDFM by replacing 2D-TTE left ventricular outflow tract (LVOT) measurements with MSCT LVOT parameters.
RESULTS: IDFM reclassified 20.4% patients as potentially non-severe AS. In a multivariable model including clinical variables, reclassification to non-severe AS by IDFM was independently associated with younger age and diabetes mellitus (DM), (Odds Ratio (OR): 0.864; 95% CI: 0.76-0.99; P < 0.035 and OR: 19.259; 95% CI: 2.28-162.41; P < 0.007, respectively). In a multivariable model including echocardiographic variables, reclassification was associated with: higher LVOT velocity time integral (VTILVOT) and lower aortic mean gradient (AMG) (OR: 1.402; 95% CI: 1.07-1.84; P < 0.014 and OR: 0.858; 95%: CI: 0.760-0.968; P < 0.013, respectively). In addition 24.1% of patients were reallocated from low-flow (< 35 mL/m²) to normal-flow AS.
CONCLUSIONS: IDFM reclassified a substantial proportion of patients with severe AS into potentially moderate AS group and from low-flow to normal-flow AS group. Such regrouping calls for increased diagnostic prudence in AS patients, especially those with specific clinical and echocardiographic predictors of reclassification, such as DM or low AMG.
AIM: The aim of the study was to establish potential predictors of AS reclassification with IDFM method.
METHODS: 54 high-risk patients (mean age 79±7.9 years; 40.7% male) with severe AS by 2D-TTE (indexed aortic valve area [AVAi] < 0.6 cm²/m²), qualified for transcatheter aortic valve implantation (TAVI), were included in the analysis. AVAi was then recalculated with IDFM by replacing 2D-TTE left ventricular outflow tract (LVOT) measurements with MSCT LVOT parameters.
RESULTS: IDFM reclassified 20.4% patients as potentially non-severe AS. In a multivariable model including clinical variables, reclassification to non-severe AS by IDFM was independently associated with younger age and diabetes mellitus (DM), (Odds Ratio (OR): 0.864; 95% CI: 0.76-0.99; P < 0.035 and OR: 19.259; 95% CI: 2.28-162.41; P < 0.007, respectively). In a multivariable model including echocardiographic variables, reclassification was associated with: higher LVOT velocity time integral (VTILVOT) and lower aortic mean gradient (AMG) (OR: 1.402; 95% CI: 1.07-1.84; P < 0.014 and OR: 0.858; 95%: CI: 0.760-0.968; P < 0.013, respectively). In addition 24.1% of patients were reallocated from low-flow (< 35 mL/m²) to normal-flow AS.
CONCLUSIONS: IDFM reclassified a substantial proportion of patients with severe AS into potentially moderate AS group and from low-flow to normal-flow AS group. Such regrouping calls for increased diagnostic prudence in AS patients, especially those with specific clinical and echocardiographic predictors of reclassification, such as DM or low AMG.
Full text links
Related Resources
Trending Papers
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Management of Diverticulitis: A Review.JAMA Surgery 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app